CMS Administrator Warns AI Will Raise Costs Before Cutting Them

Artificial intelligence will “turbocharge” medical billing and push healthcare costs up in the near term, CMS Administrator Dr. Mehmet Oz said Wednesday, September 24, 2026, according to Healthcare Dive. Oz, who leads the federal agency that runs Medicare and Medicaid, said the short-term cost increase is a tradeoff he believes will pay off through long-term savings. Healthcare Dive did not report a specific timeline, dollar figure, or mechanism for how those savings would materialize, and CMS has not published a formal policy tied to the remarks.

For the roughly 68 million Americans enrolled in Medicare, comments from the person overseeing the program's finances carry weight even when they are broad and preliminary. Medicare already leans heavily on private contractors and, increasingly, AI tools to process claims, flag improper billing, and manage prior authorization inside Medicare Advantage plans. Oz's warning signals that CMS expects AI adoption on the billing side, by providers, insurers, or both, to add complexity and cost before it streamlines anything.

Why AI-Driven Billing Could Push Costs Higher First

AI billing tools can generate claims faster and identify more billable services than manual review, which is likely the dynamic Oz referenced when he said AI would “turbocharge” billing. If providers and insurers deploy these tools before CMS updates its own fraud detection and claims-auditing systems to match, the near-term effect could be more claims volume and higher spending, not less. That is a plausible read of Oz's comments, but it is our analysis, not a detail confirmed in the reporting.

Medicare Advantage plans, which now cover more than half of all Medicare enrollees according to CMS enrollment data, already use algorithmic tools to manage utilization review and prior authorization decisions. If AI-driven billing systems on the provider side outpace AI-driven review systems on the payer side, the gap could show up in plan costs passed along through premiums, copays, or narrower provider networks in future plan years. None of this is confirmed by CMS as a direct cause of 2027 premium changes, but it is the kind of cost pressure worth watching as CMS finalizes Medicare Advantage and Part D bids for next year.

Key Takeaway

CMS Administrator Dr. Mehmet Oz says AI will raise healthcare billing costs before it lowers them, but Healthcare Dive's September 24, 2026 report does not specify a timeline or dollar impact. Medicare beneficiaries should treat this as an early signal to watch, not a confirmed change to 2027 premiums or benefits.

What This Means During the 2026 Annual Enrollment Period

The news lands just before Medicare's Annual Enrollment Period, which runs October 15 through December 7, 2026, when beneficiaries can switch Medicare Advantage plans, change Part D drug coverage, or move between Medicare Advantage and Original Medicare. Since no cost changes tied to AI billing have been announced by CMS, readers should not delay AEP decisions waiting for policy clarity that has not arrived. Instead, use the standard AEP checklist: compare each Medicare Advantage plan's total out-of-pocket maximum, check whether preferred doctors and hospitals remain in-network, and review the Part D formulary for any prescriptions taken regularly, since drug tiers and prior authorization rules can shift year to year regardless of AI adoption.

Beneficiaries who rely on services that commonly trigger prior authorization, such as imaging, durable medical equipment, or specialist referrals, may want to ask a licensed agent or their plan directly whether the plan uses automated or AI-assisted review for those approvals. That information is not always disclosed clearly in plan marketing materials, and asking directly can surface any recent changes to turnaround times or denial patterns before committing to a plan for 2027.

The Bigger Picture: A Bet on Future Savings

Oz framed the near-term cost increase as worthwhile because of expected long-term savings, a position Healthcare Dive reported as his stated view rather than a CMS finding backed by published data. CMS oversees roughly $1 trillion in annual federal healthcare spending across Medicare and Medicaid, so even modest shifts in billing efficiency, positive or negative, can move the needle on program costs that ultimately factor into Part B premiums and Medicare Advantage plan bids. Readers should watch for follow-up CMS guidance, proposed rules, or Medicare Trustees Report data that would confirm whether AI-driven billing is actually adding measurable cost, since no such figures have been released as of this report.

The practical takeaway for now is patience paired with normal plan-comparison diligence. Nothing in Oz's comments changes 2026 coverage or requires immediate action, but it is a reason to keep an eye on CMS announcements heading into 2027 plan year decisions, particularly around Medicare Advantage prior authorization rules and Part D pricing, and to consult a licensed Medicare agent when comparing plans during this fall's enrollment window.